MELK prevents radiofrequency ablation-induced immunogenic cell death and antitumor immune response by stabilizing FABP5 in hepatocellular malignancies

Abstract Background Radiofrequency ablation (RFA) is an efficient treatment with unlimited potential for liver cancer that can effectively reduce patient mortality. Understanding the biological process related with RFA treatment is important for improving treatment strategy. This study aimed to iden...

Ful tanımlama

Detaylı Bibliyografya

Asıl Yazarlar:	Bu-Fu Tang, Wang-Ting Xu, Shi-Ji Fang, Jin-Yu Zhu, Rong-Fang Qiu, Lin Shen, Yang Yang, Qiao-You Weng, Ya-Jie Wang, Jia-Yi Ding, Xiao-Jie Zhang, Wei-Qian Chen, Li-Yun Zheng, Jing-Jing Song, Biao Chen, Zhong-Wei Zhao, Min-Jiang Chen, Jian-Song Ji
Materyal Türü:	Artigo
Dil:	Inglês
Baskı/Yayın Bilgisi:	KeAi Communications Co., Ltd. 2025-01-01
Seri Bilgileri:	Military Medical Research
Konular:	Radiofrequency ablation Liver cancer Maternal embryonic leucine zipper kinase (MELK) Fatty acid-binding protein 5 (FABP5) Immune microenvironment Nanoparticles
Online Erişim:	https://doi.org/10.1186/s40779-024-00588-7
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!